top of page

CURRENT NEWS

Feb 20, 2024

FDA approves groundbreaking treatment for advanced melanoma

TIL therapy shrank tumors in about a third of patients who had run out of treatment options, according to a clinical trial.

FDA approves groundbreaking treatment for advanced melanoma

Feb 13, 2024

New Drug Shown to Relieve Pain Without Getting Patients Addicted

People who are suffering from severe pain but don’t want to risk addiction to an opioid are closer to a new option for treatment.

New Drug Shown to Relieve Pain Without Getting Patients Addicted

Feb 5, 2024

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

Each shot would be completely personalized to the patient.

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

Feb 1, 2024

FDA says 561 deaths tied to recalled Philips sleep apnea machines

The Food and Drug Administration says 561 deaths have been reported in connection to recalled Philips devices to treat obstructive sleep apnea and other breathing disorders.

FDA says 561 deaths tied to recalled Philips sleep apnea machines

Jan 9, 2024

Bayer's menopausal relief drug succeeds in late-stage trial

Bayer said its menopausal relief drug eased hot flashes and improved sleep

Bayer's menopausal relief drug succeeds in late-stage trial

Jan 8, 2024

LSD could be effective in treating anxiety, clinical trial shows

A new trial finds that LSD might have the potential to treat anxiety.

LSD could be effective in treating anxiety, clinical trial shows

Dec 26, 2023

Does food as medicine help patients with diabetes?

Here’s what a new clinical trial says.

Does food as medicine help patients with diabetes?

Dec 10, 2023

Pfizer Nixes More Study of Twice-Daily Obesity Pill Treatment That Made Many Patients Nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Pfizer Nixes More Study of Twice-Daily Obesity Pill Treatment That Made Many Patients Nauseous

Dec 9, 2023

Ginger Supplements May Reduce Inflammation Related to Autoimmune Disease

Uncover the potential benefits of ginger supplements in the fight against autoimmune conditions.

Ginger Supplements May Reduce Inflammation Related to Autoimmune Disease

Nov 12, 2023

First look at Verve study data offers base editing ‘proof of principle’

Early clinical trial results showed Verve’s therapy can substantially lower cholesterol levels by editing the genes of liver cells.

First look at Verve study data offers base editing ‘proof of principle’

Nov 7, 2023

Drugs aren’t required to be tested in people who are obese.

Here’s why that’s a problem.

Drugs aren’t required to be tested in people who are obese.

Nov 2, 2023

New treatment breakthrough

Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

New treatment breakthrough

Oct 23, 2023

Alzheimer’s therapy

Vigil Neuroscience has dosed the first subject in a Phase I clinical trial of VG-3927 to potentially treat Alzheimer’s disease (AD).

Alzheimer’s therapy

Oct 19, 2023

A new Cancer Drug

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

A new Cancer Drug

Oct 11, 2023

Concierge-Style Services Becoming a Staple In Clinical Trials

Recruit patients faster, retain more of them, and get their outcomes data sooner

Concierge-Style Services Becoming a Staple In Clinical Trials

Oct 10, 2023

A new cancer vaccine

Trials show new cancer vaccine could improve patient survival for some lung cancers by nearly half

A new cancer vaccine

Oct 5, 2023

Ketamine Nasal Spray Shows Promise Against Tough-to-Treat Depression

The nasal spray was more effective at sending patients into remission

Ketamine Nasal Spray Shows Promise Against Tough-to-Treat Depression

Oct 4, 2023

Moderna claims positive results in early study for combo COVID, flu shot

The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025.

Moderna claims positive results in early study for combo COVID, flu shot

Oct 1, 2023

Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial

Boundless Bio has announced a collaboration with Eli Lilly for its first-in-human Phase I/II trial investigating BBI-355 in solid tumours.

Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial

Sep 16, 2023

FDA Approves First RSV Vaccine For Kids—Given To Pregnant Moms

FDA Approves First RSV Vaccine For Kids—Given To Pregnant Moms

Aug 24, 2023

New Trials in Prostate Cancer

New Trials in Prostate Cancer

Aug 8, 2023

Clinical trials for long-COVID treatments underway at the National Institutes of Health

Clinical trials for long-COVID treatments underway at the National Institutes of Health

Jul 24, 2023

Daily statin reduces heart disease risk among adults living with HIV

NIH-funded clinical trial finds cholesterol-lowering treatment reduced cardiovascular events by 35%.

Daily statin reduces heart disease risk among adults living with HIV

Jul 20, 2023

Experimental Shot Given Every Six Months Controlled High Blood Pressure in Early Trial

Experimental Shot Given Every Six Months Controlled High Blood Pressure in Early Trial

Jul 11, 2023

Murray Aitken on Advancing Diversity in Clinical Development

Murray Aitken on Advancing Diversity in Clinical Development

Jul 4, 2023

MIND diet for brain health shows surprising results in new clinical trial

MIND diet for brain health shows surprising results in new clinical trial

Jun 29, 2023

Oral ‘Ozempic’ Pills For Weight Loss Could Be Coming Soon

The drugs could hit the market in 2024.

Oral ‘Ozempic’ Pills For Weight Loss Could Be Coming Soon

Jun 29, 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Jun 27, 2023

An experimental drug could offer a weight loss

Experimental drug could offer more weight loss than any drug now on the market, study finds

An experimental drug could offer a weight loss

Jun 9, 2023

FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug

FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug

Jun 1, 2023

AstraZeneca abandons experimental bowel disease drug

The drugmaker is discontinuing work on brazikumab, an IL-23 inhibitor it regained rights to following AbbVie’s acquisition of Allergan.

AstraZeneca abandons experimental bowel disease drug

May 4, 2023

Electric Fields Disrupt Cancer Cell Division

A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.

Electric Fields Disrupt Cancer Cell Division

Mar 18, 2023

Pain points: Unsolved recruitment and trial design issues in pain clinical trials

Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.

Pain points: Unsolved recruitment and trial design issues in pain clinical trials

Cancer drug

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug
bottom of page